Ls Investment Advisors, LLC Illumina, Inc. Transaction History

Ls Investment Advisors, LLC

$656 Million
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $350,058 - $425,204	-1,008 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$372.84 - $481.5 $530,178 - $684,693	-1,422 Reduced 58.52%	1,008 $477,000
Q1 2021 May 13, 2021	SELL	$361.28 - $504.76 $106,577 - $148,904	-295 Reduced 10.83%	2,430 $933,000
Q4 2020 Feb 10, 2021	SELL	$292.7 - $370.96 $41,856 - $53,047	-143 Reduced 4.99%	2,725 $1.01 Million
Q3 2020 Nov 12, 2020	BUY	$268.51 - $400.74 $18,258 - $27,250	68 Added 2.43%	2,868 $886,000
Q2 2020 Aug 10, 2020	BUY	$256.46 - $373.01 $69,500 - $101,085	271 Added 10.72%	2,800 $1.04 Million
Q1 2020 Apr 20, 2020	SELL	$209.2 - $335.53 $10,250 - $16,440	-49 Reduced 1.9%	2,529 $691,000
Q4 2019 Jan 31, 2020	SELL	$288.29 - $335.49 $14,414 - $16,774	-50 Reduced 1.9%	2,578 $855,000
Q3 2019 Oct 31, 2019	BUY	$266.84 - $378.23 $38,958 - $55,221	146 Added 5.88%	2,628 $799,000
Q2 2019 Aug 07, 2019	SELL	$300.59 - $368.15 $6,011 - $7,363	-20 Reduced 0.8%	2,482 $914,000
Q1 2019 Apr 25, 2019	BUY	$272.57 - $321.18 $12,265 - $14,453	45 Added 1.83%	2,502 $777,000
Q4 2018 Feb 01, 2019	SELL	$272.46 - $366.54 $115,523 - $155,412	-424 Reduced 14.72%	2,457 $737,000
Q3 2018 Nov 13, 2018	SELL	$279.04 - $367.06 $115,243 - $151,595	-413 Reduced 12.54%	2,881 $1.06 Million
Q2 2018 Jul 20, 2018	SELL	$228.17 - $292.07 $20,078 - $25,702	-88 Reduced 2.6%	3,294 $920,000
Q1 2018 May 08, 2018	SELL	$209.54 - $253.91 $41,488 - $50,274	-198 Reduced 5.53%	3,382 $800,000
Q4 2017 Feb 07, 2018	BUY	$202.23 - $230.03 $81,296 - $92,472	402 Added 12.65%	3,580 $782,000
Q3 2017 Oct 19, 2017	BUY	$172.3 - $213.93 $547,569 - $679,869	3,178	3,178 $633,000

Others Institutions Holding ILMN

# of Institutions

900

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.3B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.

Account